Paper Details 
Original Abstract of the Article :
Glutamatergic dysfunction is posed as a main stage in neurodegenerative disorders such as Alzheimer's disease (AD). Glutamate-mediated excitotoxicity contributes to cognitive dysfunction and cell death in AD. Ceftriaxone (CFT), a well-known upregulator of GLT-1, selectively induces the expression of...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.lfs.2019.116969

データ提供:米国国立医学図書館(NLM)

Ceftriaxone: A Potential Oasis in the Desert of Alzheimer's Disease Research

The field of Alzheimer's disease research is a vast and often frustrating desert, with researchers seeking to understand the complex mechanisms of the disease and develop effective treatments. This study explores the potential of ceftriaxone, a well-known antibiotic, as a potential therapeutic agent for Alzheimer's disease. The authors investigated the electrophysiological and behavioral effects of ceftriaxone in an okadaic acid-induced model of Alzheimer's disease, focusing on its ability to modulate glutamate transporter-1 (GLT-1) expression.

Ceftriaxone: A Potential Modulator of Glutamate-Mediated Excitotoxicity

The study found that ceftriaxone exhibited neuroprotective effects in the okadaic acid-induced model of Alzheimer's disease, suggesting its potential to reduce glutamate-mediated excitotoxicity. The findings suggest that ceftriaxone may offer a promising avenue for exploring novel therapeutic approaches to Alzheimer's disease.

Health Implications

This study provides a potential spark of hope in the desert of Alzheimer's disease research, suggesting that ceftriaxone, a commonly used antibiotic, may hold therapeutic potential. Further research is needed to confirm its efficacy and safety in human patients and to explore its long-term effects on cognitive function.

Dr.Camel's Conclusion

This study delves into the complex landscape of Alzheimer's disease research, offering a glimmer of hope in the desert of unanswered questions. The findings suggest that ceftriaxone, a seemingly simple antibiotic, may hold therapeutic potential for Alzheimer's disease. Further research is crucial to fully understand its mechanisms of action and determine its efficacy and safety in human patients.

Date :
  1. Date Completed 2019-12-17
  2. Date Revised 2019-12-17
Further Info :

Pubmed ID

31628912

DOI: Digital Object Identifier

10.1016/j.lfs.2019.116969

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.